Showing 2151-2160 of 2527 results for "".
- J&J Looking to Enroll 60,000 Participants in Coronavirus Vaccine Trialhttps://modernod.com/news/jj-looking-to-enroll-60000-participants-in-coronavirus-vaccine-trial/2478185/A phase 3 trial Johnson & Johnson is planning to get under way in September to test its coronavirus vaccine candidate Ad26.COV2.S is looking to recruit up to 60,000 participants globally, the company confirmed Thursday. The targeted enrollment, first reported on the ClinicalTrials.gov databas
- Regeneron Boosts Production Capacity for COVID-19 Antibody Cocktail Via Deal With Rochehttps://modernod.com/news/regeneron-boosts-production-capacity-for-covid-19-antibody-cocktail-via-deal-with-roche/2478176/Regeneron Pharmaceuticals said that the overall capacity to produce REGN-COV2, a two-antibody cocktail against COVID-19, will increase by at least 3.5 times under a development and manufacturing collaboration with Roche. As part of the deal, Regeneron will market REGN-COV2 in the US, with Roche r
- American Academy of Optometry Foundation Announces the 2020 Hopkins Comprehensive Eye Care Award Recipienthttps://modernod.com/news/american-academy-of-optometry-foundation-announces-the-2020-hopkins-comprehensive-eye-care-award-recipient/2478173/The American Academy of Optometry has announced that Charlotte Yiyi Wang, OD, is the recipient of this year’s recipient of the Hopkins Comprehensive Eye Care Award. Dr. Wang is a graduate of the University of California, Berkeley School of Optometry, and primary care/community health resident at
- How COVID-19 is Shaking Up Medical Education—For Goodhttps://modernod.com/news/how-covid-19-is-shaking-up-medical-education-for-good/2478168/With COVID-19 shows no signs of letting up soon, leaders at medical schools are adapting their plans for education in the fall to meet the new demands of the pandemic, according to a FierceHealthcare report. That means going digital in an unprecedented way—both in terms of classe
- Avellino Hits 1-Million Genetic Test Milestonehttps://modernod.com/news/avellino-hits-1-million-genetic-test-milestone/2478164/Avellino announced that the company has performed over 1-million genetic and molecular diagnostic tests. This milestone includes over 821,000 universal tests for TGFBI corneal dystrophy, over 180,000 AvellinoSARS-CoV-2/COVID-19 (AvellinoCoV2) tests since March 2020, and the November 2019 launch o
- EU Wraps Up Exploratory Talks With J&J to Secure Coronavirus Vaccinehttps://modernod.com/news/eu-wraps-up-exploratory-talks-with-jj-to-secure-coronavirus-vaccine/2478163/The European Commission said that it concluded exploratory talks with Johnson & Johnson to buy Ad26.COV2.S, the company’s vaccine candidate against COVID-19. Under the potential deal, once a vaccine has shown to be safe and effective against the novel coronavirus, the Commission s
- Gyroscope Therapeutics Initiates Phase 2 Program Evaluating its Investigational Gene Therapy for Dry AMDhttps://modernod.com/news/gyroscope-therapeutics-initiates-phase-2-program-evaluating-its-investigational-gene-therapy-for-dry-amd/2478157/Gyroscope Therapeutics announced the initiation of its phase 2 program evaluating its investigational gene therapy, GT005, for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). GT005 is a one-time AAV-based gene therapy that is delivered under the r
- VSY Biotechnology Launches Enova Glistening-Free Hydrophobic Acrylic IOLhttps://modernod.com/news/vsy-biotechnology-launches-enova-glistening-free-hydrophobic-acrylic-iol/2478147/VSY Biotechnology announces the launch of the Enova IOL. Enova is the first 100% glistening-free hydrophobic acrylic IOL that does not require pre-hydration or storage in saline solution, according to VSY Biotechnology. The unique composition of Enova material allows uniform hydration of s
- Gilead Files For US Approval of Veklury to Treat COVID-19https://modernod.com/news/gilead-files-for-us-approval-of-veklury-to-treat-covid-19/2478148/Gilead Sciences that it has submitted an application to the FDA seeking approval of its experimental antiviral Veklury (remdesivir) as a treatment for patients with COVID-19. The drug is currently available in the US under an emergency-use authorization for hospitalized patients severely il
- Researchers Discover Predictor of Laser Treatment Success in Patients With Glaucomahttps://modernod.com/news/researchers-discover-predictor-of-laser-treatment-success-in-patients-with-glaucoma/2478127/A new study from the University of Missouri School of Medicine and MU Health Care provides insight into which patients might benefit most from selective laser trabeculoplasty (SLT), which relieves pressure by using a laser to alter the eye tissue, resulting in better fluid drainage. “There